On January 5, 2015 Foundation Medicine, Inc. (NASDAQ:FMI) reported that the company and its collaborators will present seven poster presentations at the 2016 Genitourinary Cancers Symposium taking place January 7-9, 2016 in San Francisco (Press release, Foundation Medicine, JAN 5, 2016, View Source [SID:1234508663]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The company’s molecular information products, FoundationOne for solid tumors and FoundationOne Heme for hematologic malignancies and sarcomas, provide a comprehensive genomic profile to identify the molecular alterations in a patient’s cancer. The data to be presented at the Genitourinary Cancer Symposium provide further supporting evidence of the clinical utility of Foundation Medicine’s assays in the care of patients with genitourinary malignancies.
The schedule for poster presentations by Foundation Medicine and/or its collaborators is as follows:
Date and Time: Thursday, January 7, 2016: 11:30 a.m.-1:00 p.m. and 5:15 p.m.-6:45 p.m. PT
Title: Comprehensive Genomic Profiling of Neuroendocrine Carcinoma of the Prostate
Abstract: 187
Poster Display Location: Level 1, West Hall
Session: Poster Session A: Board H2
Co-Presenters: Sumanta Pal, M.D., assistant clinical professor, Department of Medical Oncology & Therapeutics Research co-director, Kidney Cancer Program, City of Hope and Jeffrey S. Ross, M.D., Cyrus Strong Merrill professor and chair, Department of Pathology and Laboratory Medicine Albany Medical College; medical director, Foundation Medicine
Collaborator(s): West Jefferson Medical Center, City of Hope
Date and Time: Friday, January 8, 2016: 12:15 p.m.-1:45 p.m. and 6:00 p.m.-7:00 p.m. PT
Title: Latent Class Analysis of Bladder Urothelial Carcinoma Reveals Sub-Classes Defined By Alterations to Chromatin and Signal Transduction Networks
Abstract: 469
Poster Display Location: Level 1, West Hall
Session: Poster Session B: Board K18
Presenter: Alyna Khan, analyst, Text Analytics, Foundation Medicine
Date and Time: Friday, January 8, 2016: 12:15 p.m.-1:45 p.m. and 6:00 p.m.-7:00 p.m. PT
Title: Comprehensive Genomic Profiling (CGP) of Advanced Nonseminomatous Testicular Germ Cell Tumors (NSGCT) Reveals Clinically Relevant Genomic Alterations (CRGA) to Guide Targeted Therapy
Abstract: 477
Poster Display Location: Level 1, West Hall
Session: Poster Session B: Board L2
Presenter: Siraj Ali, M.D., Ph.D., director, clinical development and medical affairs, Foundation Medicine
Collaborator(s): Cancer Care Associates of York
Date and Time: Friday, January 8, 2016: 12:15 p.m.-1:45 p.m. and 6:00 p.m.-7:00 p.m. PT
Title: Comprehensive Genomic Profiling of Urothelial Carcinoma of the Kidney and Ureter: Comparison with Urothelial Carcinoma of the Bladder and Impact on Potential for Targeted Therapy Selection
Abstract: 371
Poster Display Location: Level 1, West Hall
Session: Poster Session B: Board F6
Co-Presenters: Sumanta Pal, M.D., assistant clinical professor, Department of Medical Oncology & Therapeutics Research co-director, Kidney Cancer Program, City of Hope and Jeffrey S. Ross, M.D., Cyrus Strong Merrill professor and chair, Department of Pathology and Laboratory Medicine Albany Medical College; medical director, Foundation Medicine
Collaborator(s): City of Hope, Albany Medical Center
Date and Time: Friday, January 8, 2016: 12:15 p.m.-1:45 p.m. and 6:00 p.m.-7:00 p.m. PT
Title: Characterization of Mutational Load in Patients with Advanced Urothelial Cancer
Abstract: 460
Poster Display Location: Level 1, West Hall
Session: Poster Session B: Board K9
Presenter: Siraj Ali, M.D., Ph.D., director, clinical development and medical affairs, Foundation Medicine
Collaborator(s): City of Hope
Date and Time: Saturday, January 9, 2016: 7:00 a.m.-7:55 a.m. and 11:30 a.m.-1:00 p.m. PT
Title: Comprehensive Genomic Profiling of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations
Abstract: 537
Poster Display Location: Level 1, West Hall
Session: Poster Session C: Board E20
Presenter: Gabriel Malouf, M.D., Ph.D., assistant professor, Department of Medical Oncology, Groupe Hospitalier Pitié-Salpêtrière, University Pierre and Marie Curie (Paris VI)
Collaborator(s): MD Anderson Cancer Center
Date and Time: Saturday, January 9, 2016: 7:00 a.m.-7:55 a.m. and 11:30 a.m.-1:00 p.m. PT
Title: Correlation Between Findings from Comprehensive Genomic Profiling and Targeted Therapy Response in Metastatic Renal Cell Carcinoma
Abstract: 570
Poster Display Location: Level 1, West Hall
Session: Poster Session C: Board G9
Presenter: Thai Ho, M.D., Ph.D., assistant professor, Hematology/Oncology, Mayo Clinic
Collaborator(s): Mayo Clinic, City of Hope